Cytek Biosciences, Inc. CTKB
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2021-07-23
Cytek Biosciences, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 17,070,422 | $95.3M |
| MILLENNIUM MANAGEMENT LLC | 6,291,798 | $27.5M |
| AQR CAPITAL MANAGEMENT LLC | 912,342 | $4.0M |
| RENAISSANCE TECHNOLOGIES LLC | 676,700 | $3.0M |
| CITADEL ADVISORS LLC | 482,892 | $2.1M |
| D. E. Shaw & Co., Inc. | 260,125 | $1.1M |
| TWO SIGMA INVESTMENTS, LP | 25,600 | $111,872 |
Source: SEC EDGAR filings · CIK 0001831915 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.